- Report
- August 2025
- 199 Pages
Global
From €3134EUR$3,545USD£2,728GBP
€3482EUR$3,939USD£3,032GBP
- Report
- August 2025
- 189 Pages
Global
From €3134EUR$3,545USD£2,728GBP
€3482EUR$3,939USD£3,032GBP
- Report
- August 2025
- 194 Pages
Global
From €3134EUR$3,545USD£2,728GBP
€3482EUR$3,939USD£3,032GBP
- Report
- August 2025
- 190 Pages
Global
From €3134EUR$3,545USD£2,728GBP
€3482EUR$3,939USD£3,032GBP
- Report
- August 2025
- 197 Pages
Global
From €3134EUR$3,545USD£2,728GBP
€3482EUR$3,939USD£3,032GBP
- Report
- October 2025
- 381 Pages
Global
From €5171EUR$5,850USD£4,502GBP
- Report
- October 2025
- 272 Pages
Global
From €5171EUR$5,850USD£4,502GBP
- Report
- October 2025
- 193 Pages
Global
From €5171EUR$5,850USD£4,502GBP
- Report
- October 2025
- 131 Pages
Global
From €5171EUR$5,850USD£4,502GBP
- Report
- October 2025
- 276 Pages
Global
From €5171EUR$5,850USD£4,502GBP
- Report
- October 2025
- 258 Pages
Global
From €5171EUR$5,850USD£4,502GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2210EUR$2,500USD£1,924GBP
- Report
- December 2024
- 30 Pages
Global
From €2873EUR$3,250USD£2,501GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1768EUR$2,000USD£1,539GBP
- Clinical Trials
- July 2025
- 80 Pages
Global
From €1768EUR$2,000USD£1,539GBP
- Report
- April 2025
- 200 Pages
Global
From €7028EUR$7,950USD£6,119GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1768EUR$2,000USD£1,539GBP
- Clinical Trials
- April 2025
- 100 Pages
Global
From €1768EUR$2,000USD£1,539GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2652EUR$3,000USD£2,309GBP
- Report
- April 2025
- 200 Pages
Global
From €7028EUR$7,950USD£6,119GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more